Comparison of hepatic peroxisome proliferative effect and its implication for hepatocarcinogenicity of phthalate esters, di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate with a hypolipidemic drug.
Peroxisome proliferation is inducible in hepatocytes of rodent and nonrodent species by structurally dissimilar hypolipidemic drugs and certain phthalate ester plasticizers. The induction of peroxisome proliferation appears to be a tissue specific response limited largely to the hepatocyte. Peroxisome proliferation is associated with increases in the activity of the H2O2-generating peroxisomal fatty acid beta-oxidation system and in the amount of peroxisome proliferation-associated 80,000 MW polypeptide (PPA-80). Chronic administration of these non-DNA damaging and nonmutagenic peroxisome proliferators to rats and mice results in the development of hepatocellular carcinomas. Comparative morphometric and biochemical data from rats treated with varying dose levels of ciprofibrate, a hypolipidemic drug, and di(2-ethylhexyl) phthalate, and di(2-ethylhexyl) adipate, the widely used plasticizers, indicate that the hepatocarcinogenic potency of these agents is correlatable with their ability to induce peroxisome proliferation, peroxisomal beta-oxidation and PPA-80. Available evidence strongly favors the role of peroxisome proliferation-associated oxidative stress in the induction of liver tumors by peroxisome proliferators.
Reddy
J K
JK
Reddy
M K
MK
Usman
M I
MI
Lalwani
N D
ND
Rao
M S
MS
D000272:Adipates / Q000494:pharmacology*; D000818:Animals; D002374:Catalase / Q000378:metabolism; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D004051:Diethylhexyl Phthalate / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D058607:Fibric Acids; D008099:Liver / Q000648:ultrastructure; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced*; D008830:Microbodies / Q000187:drug effects*; D008854:Microscopy, Electron; D010084:Oxidation-Reduction; D010795:Phthalic Acids / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship
D000272:Adipates; D058607:Fibric Acids; D010795:Phthalic Acids; C013966:dioctyl adipate; D002995:Clofibric Acid; D004051:Diethylhexyl Phthalate; D002374:Catalase; C019304:ciprofibrate; D002994:Clofibrate